Persist AI
Persist AI, based in Woodland, CA, specializes in using AI-driven automation to halve the development time for long-lasting drug injections, focusing on chronic diseases such as cancer and diabetes.
Company Overview
Persist AI, also formerly known as Persist AI Formulations Corp, is a healthcare company based in Woodland, CA, USA. Founded in 2023, Persist AI utilizes advanced technologies like Machine Learning, Robotics, Microfluidics, and Nanotechnology to enhance drug discovery and delivery. The company's primary focus is on reducing the formulation development time for long-lasting drug injections by approximately 50%, targeting chronic diseases such as cancer and diabetes. The team consists of 6 members and operates in the Healthcare industry, specifically in Drug Discovery and Delivery.
Technologies Used by Persist AI
Persist AI leverages a combination of advanced technologies to achieve its goals in drug discovery and delivery. The key technologies include Machine Learning, Robotics, Microfluidics, and Nanotechnology. These technologies are utilized to automate and expedite formulation development processes, making it possible to create long-lasting drug formulations 50% faster than traditional methods. This technological suite enables Persist AI to innovate in the field of therapeutics, specifically focusing on chronic diseases like cancer and diabetes.
Services Offered by Persist AI
Persist AI focuses on providing AI-driven automation services for drug formulation development. These services aim to reduce the formulation development time for long-lasting drug injections by approximately 50%. By employing Machine Learning, Robotics, Microfluidics, and Nanotechnology, the company is able to serve regions including the United States of America, America/Canada, and provide remote and partly remote services. The company’s efforts are especially concentrated on chronic disease therapeutics, including cancer and diabetes.
Y Combinator Involvement
Persist AI was part of the Y Combinator Winter 2023 (W23) batch. Y Combinator is a renowned startup accelerator that has supported numerous successful companies. Being part of this batch provides Persist AI with the resources, mentorship, and networking opportunities to advance its innovative solutions in the healthcare industry, particularly in drug discovery and delivery. The company's inclusion in this program underscores its potential and the innovative nature of its technological approach to therapeutic development.
Regional Operations and Team Size
Persist AI operates out of Woodland, CA, USA, and provides services across multiple regions, including the United States of America and America/Canada. The company also offers remote and partly remote services. With a dedicated team of 6 members, Persist AI is in the early stages of development but is committed to making significant strides in the healthcare industry by focusing on the speed and efficiency of drug formulation development.
